Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

NGL Fine-Chem Limited

NGLFINE.BOBSE
Healthcare
Drug Manufacturers - General
2246.55
0.00(0.00%)
Indian Market opens in 11h 24m

NGL Fine-Chem Limited (NGLFINE.BO) Stock Overview

Explore NGL Fine-Chem Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.8B
P/E Ratio39.47
EPS (TTM)$57.35
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$2312.15
3 Months$630.49
1 Year Target$1506.37

NGLFINE.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NGL Fine-Chem Limited (NGLFINE.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1506.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.47 and a market capitalization of 13.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.72%
5-Day Change
-5.09%
1-Month Change
47.71%
3-Month Change
67.87%
6-Month Change
56.96%
Year-to-Date (YTD) Change
59.31%
1-Year Change
102.59%
3-Year Change
76.73%
5-Year Change
48.64%
All-Time (Max) Change
68315.64%

Contact Information

91 22 4084 2222
301, E Square, Mumbai, NaN, 400057

Company Facts

6,820 Employees
IPO DateJul 8, 2022
CountryIN
Actively Trading

Frequently Asked Questions